Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Siobhan McCormick
Observed names:
McCormick, Siobhan Elizabeth,
S. McCormick,
S. Mccormick,
S.E McCormick,
Siobhan E McCormick,
Siobhan E. McCormick,
Siobhan Mccormick
show all 7
Institution:
University of British Columbia
Observed institutions:
TRIUMF,
Mayo Clinic,
Vancouver Coastal Health,
University of British Columbia,
Mayo Clinic in Florida,
Centre for Blood Research,
Djavad Mowafaghian Centre for Brain Health
show all 7
OpenAlex ID:
A5111908721
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
2009
·
R. Nandhagopal
, L. Kuramoto
, et al.
·
Brain
·
259
Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
2010
·
Raúl de la Fuente‐Fernández
, Michael Schulzer
, et al.
·
Annals of Neurology
·
223
PDF
Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease
2019
·
Matthew A. Sacheli
, Jason L. Neva
, et al.
·
Movement Disorders
·
196
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
2011
·
Ramachandiran Nandhagopal
, Lisa Kuramoto
, et al.
·
Brain
·
167
Toward [18F]-Labeled Aryltrifluoroborate Radiotracers: In Vivo Positron Emission Tomography Imaging of Stable Aryltrifluoroborate Clearance in Mice
2008
·
Richard Ting
, Curtis Harwig
, et al.
·
Journal of the American Chemical Society
·
131
Progression of dopaminergic dysfunction in a LRRK2 kindred
2008
·
R. Nandhagopal
, E. Mak
, et al.
·
Neurology
·
120
PDF
Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers
2013
·
Claudia Jacova
, Ging-Yuek R. Hsiung
, et al.
·
Neurology
·
81
PDF
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study
2018
·
Shu-Ying Liu
, Daryl J Wile
, et al.
·
The Lancet Neurology
·
79
Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function
2009
·
André R. Troiano
, Michael Schulzer
, et al.
·
Synapse
·
57
Visualizing vesicular dopamine dynamics in Parkinson's disease
2009
·
Raúl de la Fuente‐Fernández
, Vesna Sossi
, et al.
·
Synapse
·
55
In Vivo Measurement of Density and Affinity of the Monoamine Vesicular Transporter in a Unilateral 6-Hydroxydopamine Rat Model of PD
2007
·
Vesna Sossi
, James E Holden
, et al.
·
Journal of Cerebral Blood Flow & Metabolism
·
40
In-vivo Measurement of LDOPA Uptake, Dopamine Reserve and Turnover in the Rat Brain Using [ 18 F]FDOPA PET
2012
·
Matthew D Walker
, Katherine Dinelle
, et al.
·
Journal of Cerebral Blood Flow & Metabolism
·
36
Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism
2014
·
Silke Appel‐Cresswell
, Ali H Rajput
, et al.
·
Movement Disorders
·
23
Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia
2002
·
S.E McCormick
, A.J Stoessl
·
Neuroscience
·
23
Positron emission tomography kinetic modeling algorithms for small animal dopaminergic system imaging
2009
·
Geoffrey J. Topping
, Katie Dinelle
, et al.
·
Synapse
·
19
Central administration of the neurotensin receptor antagonist sr48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia
2003
·
S.E McCormick
, A.J Stoessl
·
Neuroscience
·
18
Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
2022
·
Vesna Sossi
, Joseph R. Patterson
, et al.
·
Movement Disorders
·
14
PDF
Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging
2020
·
Noeen Malik
, Rick Kornelsen
, et al.
·
European Journal of Medicinal Chemistry
·
11
Methods for Parkinson’s rat model PET image analysis with regions of interest
2007
·
G. J. Topping
, K. Dinelle
, et al.
·
2006 IEEE Nuclear Science Symposium Conference Record
·
5
Cholinergic and striatal dopaminergic dysfunction using pet as a risk marker for developing a neurodegenerative disease in patients with idiopathic rapid eye movement sleep behaviour disorder
2013
·
J. Valerio
, V. Sossi
, et al.
·
Sleep Medicine
·
4
WITHDRAWN: PET Imaging Reveals that Etanercept Crosses the Blood-Cerebrospinal Fluid but not the Blood-Brain Barrier: Implications for Alzheimer's Disease.
2009
·
Patrick L McGeer
, Edward Tobinick
, et al.
·
PubMed
·
3
Age related changes in the dopamine system of the Sprague-Dawley rat measured via positron emission tomography
2013
·
Katherine Dinelle
, Matthew Walker
, et al.
·
Journal of Nuclear Medicine
·
1
Comparison between the ROI based and pixel based analysis for neuroreceptor studies performed on the high resolution research tomograph (HRRT)
2006
·
Vesna Sossi
, Stephan Blinder
, et al.
·
2006 IEEE Nuclear Science Symposium Conference Record
·
1
Measurements of Dopaminergic Function in the Rat Brain Using [18F]FDOPA PET and Microdialysis
2013
·
Matthew D. Walker
, Katherine Dinelle
, et al.
·
Elsevier eBooks
Autosomal-Dominant Parkinsonism Associated with a Newly Described Mutation in DNAJC13: Clinical, Imaging and Pathological Description (IN2-2.002)
2013
·
Silke Cresswell
, Ali Rajput
, et al.
·
Neurology
Show more works
View as search
Works count:
35
Citation count:
1,566
H-index:
16
I10-index:
18
Year
Topic
Type
